Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

138.08
+0.60000.44%
Volume:1.60M
Turnover:221.33M
Market Cap:263.46B
PE:20.87
High:139.42
Open:138.77
Low:137.82
Close:137.48
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.45
T/O Rate:0.09%
Dividend:4.67
Dividend Rate:3.38%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.34
PE(LYR):19.31

Loading ...

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

Dow Jones
·
Sep 01

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Stock News
·
Sep 01

Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023

Dow Jones
·
Sep 01

Movement Alert|Novartis AG Rises 6.73% in Regular Trading, MS Oral Drug Remibrutinib Meets Primary Endpoints in Phase 3 Trials

Market Focus
·
Sep 01

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live
·
Sep 01

【US Pre-Market】US Futures and Chip Stocks Fall as Global Bond Sell-Off Deepens; Gold Drops Below $4,400, Brent Crude Tops $92

TradingKey
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Why Novartis Stock is Heading for Its Best Day Since 2023 After 3 Patient Deaths

Dow Jones
·
Sep 01

Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials

Dow Jones
·
Sep 01

Novartis announces results from Phase III Remodel-1/-2 trials of remibrutinib

TIPRANKS
·
Sep 01

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

TIPRANKS
·
Sep 01

Novartis Says Remibrutinib Significantly Reduces Relapse Rates in Phase 3 Multiple Sclerosis Trials

MT Newswires Live
·
Sep 01

Movement Alert|Novartis AG Rises 5.22% in Pre-Market Trading, CAR-T Autoimmune Trial Halt Paired with Positive MS Oral Drug Data

Market Focus
·
Sep 01

Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise

Stock News
·
Sep 01

Movement Alert|Novartis AG Rises 5.19% Overnight, Pauses Eight Autoimmune CAR-T Clinical Trials Following Patient Deaths

Market Focus
·
Sep 01

Novartis Pauses Autoimmune Cell Therapy Studies After Deaths

Dow Jones
·
Sep 01

Novartis AG Falls Monday, Outperforms Market

Dow Jones
·
Sep 01

Novartis AG Falls Thursday, Underperforms Market

Dow Jones
·
Aug 28

Novartis Secures New Chinese Approval for Key Radiopharmaceutical Therapy

Stock News
·
Aug 26

BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says

MT Newswires Live
·
Aug 25